Eiko Lifesciences gets nod to acquire 51% stake in SSM Formulations

11 Dec 2025 Evaluate

Eiko Lifesciences has secured approval to acquire 51% equity shares of M/s SSM Formulations, a company operating in business of Pharmaceuticals. The Board of Directors of the company in their meeting held on December 11, 2025 have approved the same. The board has approved the acquisition of 71,71,950 shares of SSM Formulations for a consideration of Rs 18 crore. Post acquisition, SSM Formulations will become a subsidiary of the company.

The acquisition constitutes a strategic forward integration move into pharmaceutical formulations, aimed at diversifying the product portfolio and capturing higher value across the pharmaceutical supply chain. It will consolidate company’s market position in specialty chemicals, pharmaceutical intermediates and APIs, while expanding the existing API portfolio and providing access to new niche molecules and client segments. The transaction is expected to generate operational synergies and economies of scale, and the target entity’s business aligns directly with the Company’s core line of activity.

Eiko Lifesciences is a leading manufacturer, supplier and exporter of Specialty Chemicals and Pharma Intermediates in India and Globally.

Eiko Lifesciences Share Price

54.00 2.36 (4.57%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3897.70
Tata Chemicals 763.85
SRF 3102.70
Pidilite Inds. 1458.40
Deepak Nitrite 1765.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×